MedTrace Logo

A Cluster Randomized Trial to Assess the Impact of Patient and Provider Education on Use of Home Dialysis

NCT02202018 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2018-10-10

No results posted yet for this study

Summary

Patients with severe kidney failure require dialysis or transplantation to survive. For those in whom a transplant is not an option, there are two main dialysis options: hemodialysis (either incenter or at home) or home peritoneal dialysis. Home-based therapies (peritoneal and home hemodialysis) are under-utilized in many Canadian jurisdictions with the proportion of home-based therapies varying between 10 and 40% across centres. Studies show that the low use of home dialysis is due to a variety of factors, though patient and provider awareness and knowledge of home dialysis are major factors. In this cluster randomized trial, the investigators will determine whether a standardized modality education program directed at patients, in combination with a provider-directed intervention, can increase the use of home dialysis in incident dialysis patients in Canada.

Conditions

Interventions

OTHER

Active KT intervention

1. Provider \& patient-directed infographics educating patients about home dialysis will be displayed in prominent clinic wall space 2. Educational white board presentations promoting home dialysis 3. Each clinic will receive reports outlining their current use of home dialysis in incident ESRD patients compared with provincial \& national averages 4. A Canadian version of the MATCH D tool will be provided to clinic staff, to help evaluate patient appropriateness for home dialysis. 5. Each clinic will receive an in-person visit from one of the study investigators/collaborators detailing the benefits of home dialysis, and the educational tools being offered to support care within their clinic.

Sponsors & Collaborators

  • University of Manitoba

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Navdeep Tangri, MD PhD FRCPC · University of Manitoba

  • Braden Manns, MD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-11-30
Completion
2018-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02202018 on ClinicalTrials.gov